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By Rudolf W. Poolman, MD, PhD, Marc F. Swiontkowski, MD, Jeremy C.T. Fairbank, MD, FRCS,
Emil H. Schemitsch, MD, FRCSC, Sheila Sprague, MSc, and Henrica C.W. de Vet, PhD
The number of outcome instruments available for use in orthopaedic observational studies has increased dramatically in
recent years. Properly developed and tested outcome instruments provide a very useful tool for orthopaedic research.
Criteria have been proposed to assess the measurement properties and quality of health-status instruments. Unfortu-
nately, not all instruments are developed with use of strict quality criteria. In this article, we discuss these quality criteria
and provide the reader with a tool to help select themost appropriate instrument for use in an observational study. We also
review the steps for future use of outcome instruments, including the standardization of their use in orthopaedic research.
Introduction
The number of outcome instruments available has in-creased substantially since the last outcome symposiumwas published in The Journal of Bone and Joint Surgery1.
The proliferating number of scales that are available complicates
the choice faced by investigators during selection of the most
appropriate instrument2-4. Quality criteria have recently been
proposed to assess the measurement properties of health-status
instruments2,5.
Outcome instruments can be used for several purposes,
including the evaluation of patients in clinical practice6 or
clinical research1. Because the focus of this supplement is on
nonrandomized studies, we will refer to outcome instruments
that are useful in a clinical research setting rather than on those
that are useful in the assessment of individual patients during
daily clinical work4. However, an extremely important use of
these tools is to improve care. This can be accomplished by
routinely instituting the use of validated instruments in daily
clinical practice and by modifying treatment protocols on the
basis of the results.
Clinical outcomes, such as those obtained through the
imaging of fractures and through physical examination to as-
sess range of motion3,7,8 (traditionally described as objective or
hard measures), are valuable in orthopaedic research. Unfor-
tunately, these measures can be subject to interrater disagree-
ment and they often do not provide definitive answers about
whether an intervention is useful from a patient’s perspective9.
Furthermore, objective measures may also correlate poorly with
a patient’s own feelings of wellness9. In addition to objective
measures, the orthopaedic literature often includes patient-
reported, or subjective or soft outcome measures, such as the
measurement of pain or satisfaction following a procedure3,10.
Well-designed patient-reported instruments have undergone
rigorous testing and may be better validated and have greater
reproducibility than the so-called objective outcomes3. Thus,
outcome objectivity is not determined by whether a clinician
measures a parameter directly, but rather it is dependent on the
reliability or reproducibility of a finding11. It cannot be stated
that, by definition, objective measures are better than subjec-
tive measures or the other way around.
The most important feature of outcome instruments is
their ability to test whether treatment is effective in improving
symptoms or function from a patient’s point of view9. Many
funding agencies and research ethic boards insist that a quality-
of-life instrument (instruments that capture a wider perspec-
tive of the state of well-being) be included in the design of
proposed clinical studies9. In an effort to standardize outcome
measurement and reporting in arthroplasty research, The
Journal of Bone and Joint Surgery strongly encourages inclusion
of the Western Ontario and McMaster University Osteoar-
thritis Index (WOMAC) in studies that report the results of hip
and knee arthroplasty.
In this article, we will discuss types of outcome instru-
ments, suggest a conceptual model that will help eliminate
confusing terminology such as ‘‘hard’’ and ‘‘soft,’’ discuss how
to locate the appropriate outcome instruments, describe a
method to evaluate outcome instruments on the basis of qual-
ity criteria, and discuss the potential pitfalls in utilizing out-
come instruments for research purposes. Moreover, we will only
refer to validated outcome instruments.
The Conceptual Model of Patient Outcomes as Proposed
by Wilson and Cleary
Wilson and Cleary proposed a classification scheme fordifferent measures of health outcome (Fig. 1)12. They
conceptualized five levels of outcomes: 1) biological and phys-
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iological variables (level one), 2) symptom status (level two), 3)
functional status (level three), 4) general health perceptions
(level four), and 5) overall quality of life (level five)12. They
stated that the concepts of this model (i.e., the concepts en-
countered when following the levels from left to right across Fig.
1) become increasingly integrated and increasingly difficult to
define and measure12. Furthermore, they explained that, as one
draws closer to level five of the model (the right side of Fig. 1),
there are an increasing number of inputs, such as characteristics
of the individual (symptom amplification, personality and mo-
tivation, and values and preferences), characteristics of the envi-
ronment (psychological supports, social and economic supports,
and social and psychological supports), and nonmedical fac-
tors that cannot be controlled by clinicians or by the health-
care system as it is traditionally defined12.
Biological and physiological factors (level one) are com-
monly conceptualized, measured, and applied in daily clinical
practice12. Examples include the diagnosis of osteoarthritis, frac-
ture, or osteosarcoma; increased activity on a bone scan; or a
meniscal tear seen on a magnetic resonance image.
The focus then moves from specific cells or organs to the
organism as a whole when symptoms are assessed (level two)12.
At this level, both biological and physiological factors play a
role. Patients can have physiological abnormalities, such as
osteoporosis, without having symptoms. On the other hand,
symptoms may not correlate to radiographic findings, such as
the lack of radiographic abnormalities in the presence of back
pain. Thus, we need to be careful about the way that we in-
terpret measures of biological function, as factors other than
biology may influence how a symptom presents. However,
symptoms are often the primary reason why patients seek
medical attention, and therefore we need to further explore
the inconsistent relationship between biological factors and
symptoms12.
Functional status (level three) is also listed as an outcome
in the model proposed by Wilson and Cleary. Symptoms, such
as pain, have an impact on the functional status of a patient;
however, the personality and motivations of the patient are also
influential. Additionally, the social environment plays an im-
portant role. Functional status is an important outcome to be
measured in observational studies. Relationships between
symptoms and function clearly exist, but variations in func-
tioning cannot always be fully explained. Therefore, all five
levels of outcome need to be measured in an observational
study.
General health perceptions (level four) are an assimila-
tion of the previously described levels of outcome. These general
health perceptions have been shown to be allied with biolog-
ical and physiological factors; however, many other factors,
including patient expectations, affect a patient’s perception of
health, resulting in large variations within each stage of clinical
severity.
Finally, overall quality of life (level five) is the broadest
outcome. This includes a wide range of nonmedical factors as
well as experiences and feelings that humans have. Interestingly,
functional status was not as strongly associated with happiness
as one might expect12. It is hypothesized that patients may be
able to adapt to their impairment13.
In contrast to the levels of evidence, a hierarchy in quality
does not exist in the outcome levels. A higher level merely il-
lustrates the complexity of the measurement, and the different
levels of outcome should coexist in observational studies.
Fig. 1
The Wilson and Cleary conceptual model of patient outcomes. (Reprinted, with permission, from: Wilson
IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient
outcomes. JAMA. 1995;273:60. Copyright 1995, American Medical Association. All rights reserved.)
42
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 91-A d SUPPLEMENT 3 d 2009
OUTCOME INSTRUMENTS : RATIONALE FOR THEIR USE
Types of Outcome Instruments
Following the model as described above, we can identifyseveral outcome instruments. Radiographs or other types
of imaging and laboratory tests are the outcome measures that
focus on biological and physiological factors in orthopaedic
research. Symptoms in the orthopaedic patient are frequently
pain, stiffness, and loss of strength, and these symptoms are
usually captured during physical examination. To structure this
examination, clinician-based outcome instruments (such as
the Knee Society score) were developed14. Furthermore, grip
dynamometers, the Jebsen-Taylor Test of Hand Function15, and
the ‘‘Get-Up and Go’’ test16 are some additional examples of
tools that are helpful during the physical examination.
Mixed Clinician-Based and Functional Outcome Instruments
Frequently utilized in past and present orthopaedic research
are mixed clinician-based and functional outcome instruments
(these instruments are comprised of questions answered by
patients and physical examination performed by the outcome
assessor). Often, these instruments are not validated and their
outcomes are frequently dependent on the technique of the
administrator. Range of motion is often a component of mixed
scoring systems such as the Harris hip score and the Constant
shoulder assessment17,18. If physical examination or clinical
tests are a part of a scoring system, there is a high risk of
interobserver variability4. Furthermore, the weight applied to
subscales or items that are often spread over different levels of
the model by Wilson and Cleary may be arbitrary. In addition,
if scores such as pain and hip flexion are combined into one
single numerical measure, this single number may yield non-
informative conclusions4,19. For example, a patient may have an
increased range of motion but still have pain or, alternatively,
the pain may have subsided but the stiffness still exists. In
addition, the patient may have a small amount of improvement
in both pain and stiffness scores. Summarizing these findings
in a single number is not helpful to investigators or clinicians
and will not discriminate between improving and worsening
patients.
Apart from mixed clinician-based instruments, other
combinations are possible. The biological and physiological
variables, symptom status, and functional status levels in the
model by Wilson and Cleary are commonly combined. The
symptom status, general health perceptions, and overall
quality-of-life levels are also possible combinations in mixed
outcome instruments. Use of the labels of the level may clarify
matters better than use of the term mixed clinician-based in-
struments, as both biological and physiological variables and
functional status instruments may be clinician based.
We recommend not using mixed clinical and functional
outcome instruments because validated outcome instruments
that will yield reproducible results are now available.
System-Specific Outcome Instruments and
Disease-Specific Instruments
System-specific instruments are developed to evaluate condi-
tions related to one body region or, more specifically, one joint.
A system-specific instrument covers several diseases related to
the given body region. For example, several patient-reported
outcome instruments are devoted to the knee20. Condition or
disease-specific instruments evaluate the well-being of patients
with a specific disease. For example, a patient population with
osteoarthritis of the hip can be evaluated with a system-specific
instrument for the hip, but they can also be evaluated with a
disease-specific instrument that focuses on osteoarthritis.
Another example comes from carpal tunnel syndrome re-
search. The Boston Carpal Tunnel Questionnaire is valid for
the population, has good reliability, and is responsive21. We
encourage the use of a disease-specific instrument, when avail-
able, to improve sensitivity to change. Symptom or disease-
specific instruments typically have a higher sensitivity than that
obtainable with generic quality-of-life instruments. Measure-
ment properties are discussed in more detail below.
General Health-Related Quality-of-Life Instruments
Health-related quality of life is a multifactorial concept12. It
comprises physical, mental, and social factors9. These factors,
when combined, describe a person’s health and deal with a
broad range of daily activities, such as work, hobbies, and
social interactions (Wilson and Cleary level four). Thus,
health-related quality of life is how a person’s health affects his
or her ability to carry out normal social and physical activities.
General health-related quality-of-life instruments are designed
to measure this wide range of health status. In orthopaedics,
the Sickness Impact Profile, the Nottingham Health Profile,
and the Short Form-36 (SF-36)22 are most frequently used4.
More recently, the Short Form-12 (SF-12) has been devel-
oped23. The SF-12 comes with the advantage of being able to
produce the two summary scales (initially developed from the
SF-36) with considerable accuracy but with far less respondent
burden24. Accordingly, the SF-12 may be an outcome instru-
ment of choice for a situation in which a short, generic mea-
sure providing summary information on physical and mental
health status is mandatory24. Moreover, the Musculoskeletal
Function Assessment (MFA) instrument and, more recently,
the Short Musculoskeletal Function Assessment (SMFA) in-
strument have been developed25,26. These two instruments have
demonstrated good validity and are commonly used in mus-
culoskeletal research25,26.
Overall Quality-of-Life Instruments
Happiness or satisfaction during daily activities or tasks is
often as important to individuals as their ability to participate
in these daily activities9,12. To capture the patients’ overall
quality of life (Wilson and Cleary level five)12, quality-of-life
outcomes have been developed. An example includes the
Quality of Well-Being (QWB) questionnaire27.
Finding and Selecting an Outcome Instrument
Selecting an outcome instrument starts with the proposedresearch question9. After carefully framing the objective of
the study, the next step is to locate instruments most suitable to
evaluate the intervention under investigation and the patient
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population to be included in the study. One of the most ef-
fective methods of selecting an appropriate instrument is to
consult with experienced musculoskeletal clinical researchers.
Ideally, the selected outcome instruments will evaluate all five
levels of outcome as proposed by Wilson and Cleary. For
example, if a study is investigating a new surgical device for
arthroscopic shoulder stabilization and the prevention of re-
current anterior shoulder dislocation, it should start with a
suitable imaging technique, such as magnetic resonance imag-
ing. The outcome instrument should be a system-specific
(shoulder) and condition-specific (instability) instrument. Both
a general quality-of-life instrument and an overall quality-of-life
instrument could be included to help policy makers compare
the outcomes of different conditions28. However, evaluating the
level-five status of a patient according to the classification sys-
tem of Wilson and Cleary is not deemed necessary when the
aim of clinical researchers is to improve clinical practice with
regard to a specific condition.
The next step is to conduct a literature search. Consulting
a librarian is often beneficial and can improve the efficiency and
the results of a literature search. Using the ‘‘Clinical Queries’’
feature in PubMed to find the most up-to-date systematic re-
views that evaluated outcome instruments is often helpful. As of
this writing, specific search strategies29, such as those developed
for randomized controlled trials, are currently lacking and are
undergoing further evaluation. Table I lists the key contem-
porary systematic reviews that are relevant to musculoskeletal
outcome instruments. Once an outcome instrument has been
selected from a systematic review, one can apply quality criteria
as described below to select the most appropriate instrument.
In our example, two reviews could guide us30,31. Furthermore,
several researchers have published compendiums of instru-
ments to aid in the selection of outcome instruments32. Ad-
ditionally, the use of validated instruments in a daily clinical
setting has been shown to improve care. Current guidelines
recommend that practitioners who would like to improve
patient care should assess patient outcomes with use of a
validated condition-specific instrument and focus on the
functional aspects of the disease or injury secondarily25.
Quality Criteria for Outcome Instruments
Any newoutcome instrument needs to be developedwith useof strict methodological safeguards. Suggested quality cri-
teria are mostly opinion based because there is no empirical
evidence in this field to support explicit quality criteria2,9. Terwee
et al. proposed a checklist of quality criteria to evaluate the
methodological soundness of patient-reported outcome in-
struments2. These criteria include: content validity, internal
consistency, criterion validity, construct validity, reproducibility
(agreement and reliability), responsiveness, floor and ceiling
effects, and interpretability2. Below, we describe these quality
criteria for patient outcome instruments in more detail2.
Content Validity
Content validity is the extent to which the domain of interest is
comprehensively sampled by the items in the instrument2. The
developers of an outcome instrument should consider that the
measurement aim of the instrument is important and that the
content is tailored to the population of interest. For example,
in a study evaluating patients with instability of the knee, a
question about return to sports may be relevant. However,
another instrument focusing on the knee may have relevant
questions with respect to osteoarthritis (i.e., pain or stiffness),
but these questions may be less relevant to a patient who has
painless giving-way and who is unable to return to sports33.
Therefore, the investigators have to choose an instrument that
is relevant to the aim of the outcome to be measured, given the
patient population of interest.
Internal Consistency
Internal consistency is the extent to which items in a scale or
subscale are intercorrelated, thus measuring the same con-
struct2. Different items or subscales in the instrument can ask
the same questions in a slightly different manner to truly cap-
ture the respondent’s opinion or level of function. The Cron-
bach alpha is considered an adequate measure of internal
consistency, and it should be calculated for each scale or sub-
scale separately2. A low Cronbach alpha indicates a lack of
correlation between the items in a scale, which makes sum-
marizing the items unjustified. A very high Cronbach alpha
reflects high correlations among the items in the scale, which
indicate the redundancy of one or more items2.
Criterion Validity
Criterion validity is the extent to which scores on a particular
instrument relate to a so-called gold standard2. If a gold
standard is available, the outcome instrument can be com-
pared with this standard. However, as a gold standard is fre-
quently unavailable, construct validity has to be assessed.
Construct Validity
Construct validity refers to the extent to which scores on a
particular instrument relate to other measures in a manner that
is consistent with theoretically derived hypotheses concerning
the concepts that are beingmeasured2. In their paper on quality
criteria, Terwee et al. explained: Without specific a priori hy-
potheses, for example, about expected correlations between
changes in instruments measuring the same concept, or ex-
pected differences in changes between ‘‘known’’ groups, ‘‘the
risk of bias is high because retrospectively it is tempting to
think up alternative explanations for low correlations instead
of concluding that the questionnaire may not be valid.’’2
Reproducibility
Reproducibility refers to the degree to which repeated mea-
surements (test-retest) in steady populations provide similar
answers. Reproducibility is built on agreement and reliability.
Agreement is the extent to which the scores on repeated mea-
sures are close to each other (absolute measurement error).
Reliability is the extent to which patients can be distinguished
from each other, despite measurement errors (relative mea-
surement error).
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Responsiveness
Responsiveness is the ability of an instrument to detect clinically
important changes over time2. Terwee et al. offered further
clarification of this concept when they said: ‘‘We consider re-
sponsiveness to be a measure of longitudinal validity. In analogy
to construct validity, longitudinal validity should be assessed by
testing predefined hypotheses, e.g., about expected correlations
between changes inmeasures, or expected differences in changes
between ‘known’ groups. This shows the ability of a question-
naire to measure changes if they really have happened. Fur-
thermore, the instrument should be able to distinguish clinically
important change from measurement error.’’2
Floor and Ceiling Effects
Floor and ceiling effects describe the number of respondents
who achieved the lowest or highest possible score2. If a patient
TABLE I Systematic Reviews of Quality-of-Life Instruments in Orthopaedic Research
Topic Reference
Upper extremity Dziedzic KS, Thomas E, Hay EM. A systematic search and critical review of measures of disability for
use in a population survey of hand osteoarthritis (OA). Osteoarthritis Cartilage. 2005;13:1-12.
Bot SD, Terwee CB, van der Windt DA, Bouter LM, Dekker J, de Vet HC. Clinimetric evaluation of
shoulder disability questionnaires: a systematic review of the literature. Ann Rheum Dis. 2004;63:335-41.
Michener LA, Leggin BG. A review of self-report scales for the assessment of functional limitation
and disability of the shoulder. J Hand Ther. 2001;14:68-76.
Salerno DF, Copley-Merriman C, Taylor TN, Shinogle J, Schulz RM. A review of functional status
measures for workers with upper extremity disorders. Occup Environ Med. 2002;59:664-70.
Bialocerkowski AE, Grimmer KA, Bain GI. A systematic review of the content and quality of wrist outcome
instruments. Int J Qual Health Care. 2000;12:149-57.
Keskula DR, Lott J. Defining and measuring functional limitations and disability in the athletic shoulder.
J Sport Rehabil. 2001;10:221-31.
Dowrick AS, Gabbe BJ, Williamson OD, Cameron PA. Outcome instruments for the assessment of the
upper extremity following trauma: a review. Injury. 2005;36:468-76.
Lower extremity Drake BG, Callahan CM, Dittus RS, Wright JG. Global rating systems used in assessing knee
arthroplasty outcomes. J Arthroplasty. 1994;9:409-17.
Garratt AM, Brealey S, Gillespie WJ, DAMASK Trial Team. Patient-assessed health instruments for
the knee: a structured review. Rheumatology (Oxford). 2004;43:1414-23.
Terwee CB, Mokkink LB, Steultjens MP, Dekker J. Performance-based methods for measuring the
physical function of patients with osteoarthritis of the hip or knee: a systematic review of measurement
properties. Rheumatology (Oxford). 2006;45:890-902.
Haywood KL, Hargreaves J, Lamb SE. Multi-item outcome measures for lateral ligament injury
of the ankle: a structured review. J Eval Clin Pract. 2004;10:339-52.
Eechaute C, Vaes P, Van Aerschot L, Asman S, Duquet W. The clinimetric qualities of patient-assessed
instruments for measuring chronic ankle instability: a systematic review. BMC Musculoskelet
Disord. 2007;8:6.
Spine Hallin P, Sullivan M, Kreuter M. Spinal cord injury and quality of life measures: a review of
instrument psychometric quality. Spinal Cord. 2000;38:509-23.
Zanoli G, Stro¨mqvist B, Padua R, Romanini E. Lessons learned searching for a HRQoL instrument to
assess the results of treatment in persons with lumbar disorders. Spine. 2000;25:3178-85.
Grotle M, Brox JI, Vøllestad NK. Concurrent comparison of responsiveness in pain and functional status
measurements used for patients with low back pain. Spine. 2004;29:E492-501.
Moreau CE, Green BN, Johnson CD, Moreau SR. Isometric back extension endurance tests: a review of the
literature. J Manipulative Physiol Ther. 2001;24:110-22.
Kettler A, Wilke HJ. Review of existing grading systems for cervical or lumbar disc and facet joint degeneration.
Eur Spine J. 2006;15:705-18.
Costa LO, Maher CG, Latimer J. Self-report outcome measures for low back pain: searching for international
cross-cultural adaptations. Spine. 2007;32:1028-37.
General osteoarthritis Veenhof C, Bijlsma JW, van den Ende CH, van Dijk GM, Pisters MF, Dekker J. Psychometric evaluation of
osteoarthritis questionnaires: a systematic review of the literature. Arthritis Rheum. 2006;55:480-92.
Sun Y, Stu¨rmer T, Gu¨nther KP, Brenner H. Reliability and validity of clinical outcome measurements of
osteoarthritis of the hip and knee—a review of the literature. Clin Rheumatol. 1997;16:185-98.
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scores the highest possible score (that is, best health status)
preoperatively, the outcome instrument cannot measure im-
provement after the treatment. This ceiling effect may be ob-
served when outcome instruments that were designed to
evaluate patients with severe disease are used to evaluate pa-
tients who are more fit. For example, an instrument designed
to evaluate elderly patients with osteoarthritis is less suitable
for evaluating improvement after treatment in a group of
athletes. This example stresses the importance of choosing an
instrument according to the population for which it was
originally designed.
Interpretability
Interpretability is the degree to which one can assign quali-
tative meaning to quantitative scores2. A difference of five
points between two treatment groups on a scale ranging from
0 to 100 points may be significant, but this does not mean
that such a small difference is also clinically relevant. An
instrument with a high degree of reproducibility may be able
to detect small changes34; however, investigators should de-
cide a priori on the clinical relevance of the spectrum of that
scale. On a 100-point scale, are patients with a 5-point higher
score really experiencing an important change, or is a change
in health status as reflected in a difference of 20 points the
minimally important change35,36? This raises an important
issue, especially since calculations regarding sample size are
often performed on the best estimates of ‘‘important treatment
effects.’’ Not only is the choice of a primary end point im-
portant, but the relevance of change on a scale should also be
known35,36.
Pitfalls Involved with the Use of Outcome Instruments in
Orthopaedic Research
Other Methodological Considerations
If multiple outcome instruments are used in an observa-tional study, then positive results can be an effect of chance
alone37. The occurrence of an erroneous false-positive con-
clusion is designated as a type-I or alpha error. Therefore,
investigators should carefully choose the most appropriate
outcome instrument a priori. We advise researchers to con-
sider choosing an instrument for each outcome level unless
the intervention is specifically focused on one or two levels.
For example, if the intervention is aimed to help patients cope
with their symptoms, it would not be necessary to make use
of the Wilson and Cleary classification system to measure bi-
ological and physiological variables. The advice to cover several
levels will result in multiple end points. Five well-defined
outcome measures will strengthen a study, thus covering all
aspects of orthopaedic outcome measurement. It is important,
however, that the investigators define their primary outcome of
interest, as multiple end points increase the risk of having
false-positive results37. If multiple outcomes are used, a sta-
tistical correction, (that is, the Bonferroni method) is recom-
mended37,38. For instance, if an investigator plans to conduct
five tests of significance on five different outcome measures
and report significance at the p < 0.05 level, the effective
probability value is not 0.05 but rather can be approximated
by a rule of thumb (5 outcomes · 0.05 = 0.25). Using this rule
of thumb, there is a 25% chance of having a false-positive
result among the five outcome measures. To limit such in-
correct conclusions (alpha errors), the alpha level of signifi-
cance can be adjusted from 0.05 to 0.01 (0.05O 5 outcomes =
0.01)37. Data dredging (this process refers to multiple testing
until one test shows positive results without the use of an a
priori hypothesis) can be a problem in retrospective case series,
in which protocols can be adjusted to the investigator’s con-
venience after analyzing the data, thus resulting in flawed
conclusions.
Another hazard exists when only the parts of the in-
strument that show a significant result after statistical testing
are reported, not the complete instrument. Instruments are
designed to be used in their original form, since the instrument
was validated as such. Modification of validated outcome in-
struments without revalidation may result in flawed conclu-
sions39,40. After modification of an outcome instrument, the
instrument should undergo the same rigorous validation
process as the original instrument did39. Simply adding or re-
moving questions for one’s own convenience violates the va-
lidity of an outcome instrument and is strongly discouraged.
Orthopaedic research will have more impact if a core set of
unmodified outcome instruments are used in all observational
studies.
Application of an outcome instrument needs to be
accomplished by blinded or independent study personnel to
help reduce bias. Although it is the patient who provides the
outcome that is assessed, there is always a risk that an in-
terviewer may have guided the responses of the patient39.
Unblinded outcome assessment may yield a threefold in-
crease in treatment effect39. In addition, if patients believe that
the information that they give on a questionnaire about
symptoms or function will be reported to their treating sur-
geon, they often will not provide accurate information because
they may appreciate the surgeon’s efforts to help them and
because they may not want to disappoint. This is why it is so
critical to use blinding techniques or enlist the services of
someone who is independent of the treating team to admin-
ister the instrument.
Cultural and Linguistic Considerations for a
Specific Population
A patient from the United States may respond differently to
certain questions than a patient from the United Kingdom
would, even though both are native English speakers4. De-
pending on the geographic locations involved, words can have
subtly different meanings. Therefore, it is very important to
consider the population on which the outcome instrument was
originally tested41.
Language barriers are another difficulty in clinimetrics
(a methodological discipline that focuses on the quality of clin-
ical measurements, e.g., diagnostic characteristics and disease
outcomes). Simply translating a previously validated instru-
ment is insufficient42. The translated instrument needs to be
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revalidated before it can be utilized in clinical or research
settings. The Disabilities of the Arm, Shoulder and Hand
(DASH) outcome measure is an example of a validated in-
strument that has been translated into several languages43-46.
Other translated and validated instruments focus on hip and
knee osteoarthritis (e.g., the Hip Disability and Osteoarthritis
Outcome Score [HOOS]47,48, the Knee Injury and Osteoar-
thritis Outcome Score [KOOS]49, and the Oxford 12-Item Knee
Questionnaire50). These issues are becoming increasingly im-
portant for multicenter cohort studies.
Mental conditions, such as posttraumatic conditions,
may complicate the ability of patients to fill out instruments.
Injury may also physically impair the patient’s hand function
and thus the patient’s ability to respond to a mailed instru-
ment requiring a written response. Jackowski and Guyatt
summarized methods to administer outcome instruments
(Table II)9.
The Future of Outcome Measurement
In the future, the development of a computer-based out-come assessment that incorporates the item response
theory may bring much progress51, but, until then, the
standardization of outcome instrument use in orthopaedic
research will be a giant leap forward. Ideally, a core set of
validated patient-reported outcome instruments should be
used in orthopaedic research. We should take a lesson from
rheumatology research, in which standardization of outcome
measurement has brought much success52. Additionally, pain
TABLE II Modes of Administration of Outcome Instruments
9
*
Mode of Administration Advantages Disadvantages
Interviewer Maximal response rate Costly
Can clarify questions Interviewer bias
Higher completion rate Reporting bias
Control over who is the respondent Characteristics of the interviewer (voice
inflections, age, race, or gender) may
introduce bias
Control over the order of questions
Telephone Greater response rate than that
obtained with mail-out
Excludes those without access
to a telephone
Relatively inexpensive Voice inflections of the interviewer
may introduce biasRelatively quick data collection
Interviewer can probe for incomplete
answers
Data collector can get clarification for
ambiguous answers
Mail Relatively inexpensive Response rates generally low
No bias introduced through the interviewer Possibility of bias because of nonresponse
May reach more respondents No control over who is the respondent
Respondents can take time to
locate certain information
May misunderstand the question
May miss questions (incomplete)
Questionnaire may be lost in the mail
Excludes illiterate, less-educated, disabled,
and/or non-English speaking populations
Computer-based
(including interactive
voice-response
technology)
Consistent presentation Demands subject sit or stand in front of a screen
Prompts for omissions Demands some computer skills
Can be web based
Reliable scoring
Easy transfer to database
Self Maximal response rate May misunderstand the question
Inexpensive May miss questions (incomplete)
Proxy Can collect information on patients who
otherwise are not represented
Response may differ from that of target
respondent
*Reproduced, with modification, from: Jackowski D, Guyatt G. A guide to health measurement. Clin Orthop Relat Res. 2003;413:86. Reprinted
with permission of Wolters Kluwer Health and Lippincott Williams and Wilkins.
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researchers have put substantial efforts into producing con-
sensus outcome measures53. Reaching consensus is not an
easy process, however, and the results from consensus
meetings need to be subject to ongoing debate54. Still, inves-
tigators could use these core instruments and then choose
additional outcome instruments, if needed, to suit the unique
nature of their study. The use of universal, previously validated
outcome instruments will facilitate a comparison of results of
different studies and will also facilitate subsequent meta-
analysis55. Before embarking on the development of yet an-
other outcome instrument, investigators should perform a
systematic review to evaluate the current state of the art56. In
terms of improving patient care, there is much more to be
gained from utilizing the currently available instruments in
clinical outcomes research than from developing a new
instrument.
Summary
Validated outcome instruments are a useful tool in or-thopaedic research. Unfortunately, not all instruments
have been developed with use of strict quality criteria. The
conceptual model of patient outcomes that was proposed by
Wilson and Cleary can help in choosing an instrument to
measure all five levels of outcome15. The proposed criteria of
Terwee et al. may help in future validation of outcome in-
struments2. As the number of validated outcome instruments
continues to increase, a method of standardization, based on
evidence and international consensus, could be helpful in
future orthopaedic research and may improve the quality of
patient care. n
NOTE: The authors thank Daniel Vena for the editing and proofreading of this paper.
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